How to Take BPC-157: Routes, Dosing & Complete Protocol

Subcutaneous injection delivers BPC-157 into the fat layer just beneath the skin. This is the default route for most users and the method used in the majority of animal research.

Why subcutaneous wins for most situations: - Bioavailability is approximately 90%, meaning nearly all of the injected peptide reaches systemic circulation - Absorption is steady and predictable, with peak plasma levels within 15 to 30 minutes - The technique is simple enough to learn in 5 minutes - Insulin syringes (29 to 31 gauge) cause minimal discomfort - You can inject near the injury site to maximize local tissue concentration

Best for: Tendon injuries, ligament sprains, muscle tears, joint pain, post-surgical recovery, and any localized musculoskeletal condition. For specific knee injection guidance, see our knee injection site guide.

Injection sites: Lower abdomen (2 inches from the navel), near the injury, outer thigh, or upper arm. Rotate sites daily to prevent tissue irritation. For a complete step-by-step injection walkthrough including needle gauge selection and sterile technique, see how to inject BPC-157. A 200lb male and a 130lb female use the same dose at the same sites. For weight-specific protocol details, see the 200lb male dosing guide.

Intramuscular injection places the peptide directly into muscle tissue. Absorption is slightly faster than subcutaneous, with peak plasma concentration within 10 to 20 minutes.

When to consider intramuscular: - Deep muscle injuries (quad tear, hamstring strain, rotator cuff) - When you want to place the peptide as close to the damaged muscle fiber as possible - If subcutaneous fat is minimal and subcutaneous injection feels uncomfortable

Technique differences from subcutaneous: - Use a 25 to 27 gauge needle, 1 inch length - Insert at a 90-degree angle (not 45 degrees) - Inject into the deltoid, vastus lateralis (outer thigh), or gluteus medius - Aspirate briefly before injection to confirm you have not entered a blood vessel

Drawback: Intramuscular injections carry a slightly higher risk of bruising and post-injection soreness. Most practitioners still prefer subcutaneous for BPC-157 because the peptide enters systemic circulation from any injection site and reaches damaged tissue through the bloodstream regardless of where you inject.

BPC-157 is one of the few peptides that survives stomach acid. This property distinguishes it from nearly every other research peptide, which would be destroyed by gastric enzymes within minutes. The oral stability of BPC-157 has been confirmed across multiple studies, consistent with its origin as a fragment of a gastric protein (Sikiric et al., Curr Pharm Des, 2018).

Oral bioavailability runs approximately 30 to 50% compared to injection, meaning you need a higher dose to achieve equivalent systemic levels.

Best for: Gut conditions (IBS, intestinal permeability, gastric ulcers, colitis). When you swallow BPC-157, it contacts the entire gastrointestinal lining directly before entering systemic circulation. This first-pass exposure delivers concentrated peptide exactly where gut injuries occur.

Format: Oral BPC-157 comes as capsules, tablets, or liquid solutions. The arginine salt form (BPC-157-Arg) is the most stable oral preparation. Some users dissolve lyophilized BPC-157 powder in water and drink it, though capsule formulations provide more consistent dosing.

Not ideal for: Musculoskeletal injuries where you want maximum bioavailability and targeted delivery near the injury site. If you are healing a torn tendon or sprained ligament, inject subcutaneously near the injury instead.

For more on oral BPC-157 research, see the BPC-157 peptide profile.

Before your first injection, confirm you have everything on hand:

• Reconstituted BPC-157 vial (stored in the refrigerator)
• Insulin syringe: 29 to 31 gauge, 0.5 inch needle, 0.5mL or 1mL capacity
• Alcohol swabs (70% isopropyl alcohol)
• Sharps container for used needles
• Clean, flat surface with good lighting

Never reuse syringes. Each injection requires a fresh, sterile needle. Using a dull or contaminated needle introduces bacteria directly into subcutaneous tissue, creating an infection risk that no amount of peptide can fix.

1. 1.Wash your hands thoroughly with soap and water for at least 20 seconds.
2. 2.Swab the vial stopper with an alcohol pad and let it air dry for 10 seconds.
3. 3.Pull back the syringe plunger to the number of units you need (see the dosing table below).
4. 4.Insert the needle through the center of the rubber stopper.
5. 5.Push air into the vial (this equalizes pressure and makes drawing easier).
6. 6.Invert the vial so the needle tip sits in the liquid.
7. 7.Pull the plunger back slowly to your target volume. If you see bubbles, flick the syringe gently and push them back into the vial.
8. 8.Withdraw the needle from the vial.

Use the peptide reconstitution calculator if your vial size or water volume differs from these standard options.

1. 1.Choose your injection site. Lower abdomen (2 inches from the navel) is easiest for beginners. For localized injuries, inject within 1 to 3 cm of the damaged tissue.
2. 2.Swab the injection site with a fresh alcohol pad. Let it air dry completely. Injecting through wet alcohol stings.
3. 3.Pinch a fold of skin between your thumb and index finger.
4. 4.Insert the needle at a 45-degree angle in one smooth motion. Do not hesitate or jab.
5. 5.Release the skin pinch.
6. 6.Push the plunger slowly and steadily. Rushing causes unnecessary pressure under the skin.
7. 7.Count to 5 with the needle still inserted. This allows the liquid to disperse before withdrawal.
8. 8.Withdraw the needle at the same angle you inserted it.
9. 9.Press gently with a clean cotton pad if there is any bleeding. Do not rub.
10. 10.Dispose of the syringe in a sharps container immediately.

The entire process takes under 2 minutes once you have practiced it a few times. Most users report feeling little more than a brief pinch. If you experience burning at the injection site, the peptide may be too cold; let the vial sit at room temperature for 3 to 5 minutes before drawing your dose.

Start at the lower end. Take 250mcg per day for the first 3 to 5 days. If you tolerate it without issues, increase to 500mcg. Jumping straight to 500mcg twice daily is unnecessary for most conditions and wastes peptide. For more on BPC-157 and exercise recovery, see our muscle growth article.

It does not. BPC-157 works through receptor-mediated signaling, not plasma concentration. A 130lb woman and a 250lb man use the same 250 to 500mcg daily dose. The peptide binds to receptors in injured tissue and triggers downstream repair cascades (VEGF upregulation, FAK-paxillin activation, nitric oxide modulation). Once those receptors fire, the signal reaches full strength regardless of body mass.

Animal studies use weight-based dosing (10mcg/kg in rats), but FDA body surface area conversion yields approximately 1.6mcg/kg for humans. For a 90kg adult, that calculates to roughly 144mcg, which falls at the low end of the 250 to 500mcg clinical range. The calculation produces nearly identical human doses whether you start with a 60kg or 120kg subject. For the full breakdown, see BPC-157 dosage for a 200lb male.

For women-specific protocol considerations, see BPC-157 benefits for women.

Both work. The question is whether local concentration or convenience matters more for your situation.

Near the injury: Injecting subcutaneously within 1 to 3 cm of the damaged tissue delivers a high local concentration during the initial diffusion phase. Cerovecki et al. (2010) demonstrated that local BPC-157 administration improved ligament healing across functional, biomechanical, and histological measures in a rat MCL transection model. Local delivery consistently outperformed systemic delivery in that study.

Abdomen (systemic): The peptide enters systemic circulation and reaches all tissues, including the injury. Concentration at the injury site is lower than with local injection, but still therapeutic. Abdominal injection is easier, less intimidating for beginners, and perfectly appropriate when injury location is difficult to access or when the target is a deep structure.

Split protocol: Some users inject 60 to 70% of their daily dose near the injury and the remaining 30 to 40% in the abdomen. No published study validates this split approach, but the pharmacological reasoning is sound: maximize local tissue saturation while also providing systemic coverage.

For detailed injection site maps by knee injury type, see our knee injection guide.

1. 1.Remove the plastic cap from the BPC-157 vial, exposing the rubber stopper.
2. 2.Swab the stopper with an alcohol pad.
3. 3.Draw bacteriostatic water into a syringe. For a 5mg vial, draw 2mL (the most common and practical dilution).
4. 4.Insert the needle through the rubber stopper at an angle, aiming the tip at the glass wall inside the vial.
5. 5.Release the water slowly down the inside wall of the vial. Do not spray it directly onto the powder. Direct impact can damage the peptide's molecular structure.
6. 6.Let it dissolve. Gently swirl the vial in circular motions. Never shake. Aggressive shaking denatures the peptide chain. The powder should dissolve within 30 to 60 seconds, producing a clear, colorless solution.
7. 7.Label the vial with the date of reconstitution and the concentration (e.g., "5mg/2mL = 2500mcg/mL").
8. 8.Store immediately in the refrigerator at 2 to 8 degrees Celsius.

Use bacteriostatic water, not sterile water — if you need a source, see where to buy bacteriostatic water for injection. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth and keeps your reconstituted peptide safe for up to 30 days. Sterile water has no preservative and allows bacterial contamination within 24 to 48 hours. For storage specifics, see does bacteriostatic water need to be refrigerated. For a detailed guide on reconstitution technique for all peptides, see how to reconstitute peptides. For information on how long your reconstituted peptide remains potent, see how long reconstituted peptides last.

The amount of bacteriostatic water you add determines the concentration, which determines how many units you draw per dose.

The 2mL dilution in a 5mg vial is the sweet spot for most users. It produces 20-unit draws for a 500mcg dose, which is easy to measure accurately on a standard 1mL insulin syringe (each small tick mark = 1 unit). Very small volumes (5 units) are harder to measure precisely and increase dosing error.

Use the peptide reconstitution calculator for custom vial sizes and water volumes.

A 4-week cycle is sufficient for mild injuries (tendonitis, strains). Moderate injuries (partial tears, chronic tendinopathy) typically require 6 to 8 weeks. Severe injuries and post-surgical recovery may warrant 8 to 12 weeks, though evidence for cycles beyond 8 weeks is limited to clinical observation rather than published research.

BPC-157 interacts with the dopaminergic system, which regulates alertness and wakefulness (Sikiric et al., J Physiol Paris, 1999). Approximately 10 to 15% of users report mild sleep disruption when injecting in the evening. The effect is typically subtle: slight difficulty falling asleep rather than full insomnia.

Morning injection (recommended for most users): Inject between 6 AM and 10 AM. This aligns with your body's natural cortisol peak and avoids any potential interference with evening melatonin production. The downstream healing processes BPC-157 triggers (collagen synthesis, angiogenesis, growth factor release) persist for hours regardless of when you inject.

Evening injection (acceptable if no sleep issues): Some users prefer evening injection to align with the body's overnight tissue repair window. Growth hormone peaks during deep sleep, and BPC-157's VEGF upregulation may theoretically complement this process. If evening dosing disrupts your sleep, switch to morning immediately.

Twice-daily dosing: Inject once in the morning and once in the early afternoon (before 3 PM). Avoid a late evening second dose.

For a deep dive on BPC-157 and sleep, see does BPC-157 cause insomnia.

Food: No established interaction with meals for injectable BPC-157. You can inject before, during, or after eating without affecting absorption. For oral BPC-157, take it on an empty stomach (at least 30 minutes before food) to maximize contact with the GI lining and reduce interference from digestive enzymes.

Exercise: Inject at least 20 to 30 minutes before or after training. Intense exercise increases blood flow and heart rate, which may accelerate peptide clearance from the injection site before adequate local absorption occurs. Some users prefer post-workout injection to coincide with the body's natural inflammatory repair response triggered by exercise.

Other peptides: If stacking BPC-157 with other peptides, inject them at separate sites but at the same time of day. Drawing multiple peptides into a single syringe is technically possible but introduces contamination risk between vials. Use separate syringes.

• Refrigerator (2 to 8 degrees Celsius): Stable for 12 to 24 months
• Room temperature: Stable for 3 to 6 months, but refrigeration is always preferred
• Freezer (-20 degrees Celsius): Stable for 2 or more years (ideal for long-term storage of unopened vials)
• Avoid: Direct sunlight, temperatures above 30 degrees Celsius, humidity

Lyophilized BPC-157 is resilient. A few hours at room temperature during shipping will not destroy it. But once you receive your order, place it in the refrigerator or freezer within 24 hours.

• Refrigerator (2 to 8 degrees Celsius): Use within 30 days
• Room temperature: Potency drops measurably within 10 to 14 days; avoid leaving reconstituted vials unrefrigerated
• Freezer: Do not freeze reconstituted peptides. Ice crystal formation damages the peptide structure

After reconstitution, the clock starts. Mark the date on the vial with a marker. If your cycle runs longer than 30 days at 500mcg daily from a single 5mg vial (it will not, since a 5mg vial provides only 10 days at 500mcg/day), reconstitute a fresh vial.

Never leave a reconstituted vial on the counter while you inject. Remove it from the fridge, draw your dose, and return it within 2 minutes. Cumulative room-temperature exposure adds up over a 10 to 30 day use period.

For the full storage guide covering all peptides, see how to store peptides. For degradation timelines, see how long reconstituted peptides last.

Mistake 1: Using sterile water instead of bacteriostatic water. Sterile water contains no preservative. Bacteria begin colonizing the vial within 24 to 48 hours of reconstitution. By day 5, you are injecting a bacterial broth along with your peptide. Bacteriostatic water (0.9% benzyl alcohol) prevents this for up to 30 days.

Mistake 2: Shaking the vial after reconstitution. Vigorous shaking denatures the peptide chain through a process called agitation-induced aggregation. The BPC-157 molecules unfold and clump together, reducing potency. Always swirl gently in circular motions.

Mistake 3: Injecting too fast. Rapid injection creates a bolus of liquid that pools under the skin and causes stinging, redness, and a visible lump. Push the plunger slowly over 3 to 5 seconds. Let the liquid disperse naturally through subcutaneous tissue.

Mistake 4: Not rotating injection sites. Injecting in the same spot every day creates localized tissue irritation, small lumps, and potentially lipodystrophy (changes in fat tissue structure) over weeks. Rotate between at least 3 to 4 sites, even when injecting near an injury. Move the injection point by 1 to 2 cm each day within the target area.

Mistake 5: Miscalculating the concentration. If you add 2mL of bacteriostatic water to a 5mg vial, the concentration is 2500mcg/mL, and 500mcg equals 20 units. If you mistakenly calculate it as 5000mcg/mL (the concentration for 1mL dilution), you will inject half your intended dose. Always double-check your math or use the BPC-157 dosage calculator.

Mistake 6: Quitting after 1 week. BPC-157 initiates cellular repair processes that take time to produce noticeable results. Tendon healing requires 3 to 6 weeks of consistent signaling. Users who stop at day 7 because they "don't feel anything" abandoned the protocol before it had time to work.

Mistake 7: Running indefinitely without breaks. Continuous BPC-157 use beyond 8 to 12 weeks risks receptor downregulation. The dopamine and serotonin receptors that BPC-157 modulates may become less sensitive, reducing the peptide's effectiveness. Standard practice is 4 to 8 weeks on, followed by 2 to 4 weeks off.

Mistake 8: Starting at the maximum dose. Jumping to 500mcg twice daily (1000mcg total) on day one is unnecessary. The research literature shows therapeutic effects at much lower doses. Start at 250mcg once daily for 3 to 5 days, assess your response, and titrate upward only if needed.

Mistake 9: Ignoring side effects. BPC-157 has an excellent safety profile in animal studies, with no lethal dose identified across 36 published studies (Kang et al., 2025 systematic review). But individual responses vary. If you experience persistent blood pressure changes, sleep disruption, or any unusual symptoms, reduce the dose or stop and consult a healthcare provider. For liver safety information, see does BPC-157 cause liver damage.

Bacterial contamination is the most dangerous risk of self-administered peptide injection. It occurs when:

• You use non-sterile water for reconstitution
• You touch the rubber stopper or needle tip with your fingers
• You reuse syringes
• You store reconstituted peptides at room temperature for extended periods
• You use a vial that has been reconstituted for more than 30 days

Signs of a contaminated vial: cloudiness, visible particles, color change (from clear to yellow or brown), unusual smell. If you observe any of these, discard the vial immediately.

Signs of injection site infection: redness that spreads beyond 2 cm from the injection point, warmth, swelling that increases over 24 to 48 hours, pus, fever. Seek medical attention immediately. Do not attempt to treat an injection site infection with more BPC-157.

A concentration miscalculation can cause you to inject 2x, 5x, or 10x your intended dose. While BPC-157 has shown no lethal dose in any published study (doses up to 20mg/kg in animals and 20mg IV in a human pilot study produced no adverse events (Staresinic et al., 2025)), massive overdosing wastes expensive peptide and may increase the risk of side effects like blood pressure fluctuation or sleep disruption.

The most common error: confusing a 5mg vial with a 10mg vial. If you add 2mL of water to a 10mg vial thinking it contains 5mg, you will calculate the concentration as 2500mcg/mL when it is actually 5000mcg/mL. Every injection will deliver double your target dose. Always verify the vial label before reconstitution.

Second most common error: confusing mL with units. 0.20mL equals 20 units on an insulin syringe. If you read "20" as 0.02mL instead of 0.20mL, you inject one-tenth of your intended dose. Familiarize yourself with insulin syringe markings before your first injection.

BPC-157 is not regulated by the FDA. Quality varies dramatically between suppliers. Underdosed, mislabeled, and outright counterfeit vials circulate widely. A vial labeled "5mg BPC-157" may contain 2mg, 0mg, or an entirely different compound.

Protective measures: - Buy from suppliers that provide third-party certificates of analysis (COA) for each batch - Verify the COA includes HPLC purity testing (should show 98% or higher purity) and mass spectrometry confirmation - Check that the lot number on the COA matches the lot number on your vial - Store properly upon receipt (refrigerate immediately)

For complete safety guidance on peptide sourcing and use, see the peptide safety guide.